Skip to main content

Month: July 2022

Clever Leaves strengthens German presence through expanded Cantourage partnership

The Partnership with Cantourage will now include Clever Leaves’ Premium Cannabinoids from the Company’s Portugal Facility to serve German pharmacies BOCA RATON, Fla., July 11, 2022 (GLOBE NEWSWIRE) — Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW) (“Clever Leaves” or the “Company”), a multinational operator and licensed producer of pharmaceutical-grade cannabinoids, announced today the continued expansion of the Company’s partnership with European medical cannabis leader Cantourage GmbH (“Cantourage”) to include supply of Clever Leaves’ second pharmaceutical-grade cannabis product, cultivated in the Company’s Portugal Facilities, to the German medicinal cannabis market. Clever Leaves will supply Cantourage with high-THC dried flower product from the Company’s Wappa strain, cultivated in Clever Leaves’ facility in Portugal, where...

Continue reading

Reneo Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

IRVINE, Calif., July 11, 2022 (GLOBE NEWSWIRE) — Reneo Pharmaceuticals, Inc. (Nasdaq: RPHM), a clinical stage pharmaceutical company focused on the development and commercialization of therapies for patients with rare genetic mitochondrial diseases, today announced that the Compensation Committee of Reneo’s Board of Directors (the Compensation Committee) granted inducement awards to a non-executive new employee, consisting of an option to purchase an aggregate of 75,000 shares of common stock, plus a performance-based restricted stock unit award covering 25,000 shares of common stock. The Compensation Committee approved the awards as inducements material to such non-executive new employee entering employment with Reneo in accordance with Nasdaq Listing Rule 5635(c)(4). About Reneo Pharmaceuticals Reneo is a clinical-stage pharmaceutical...

Continue reading

CareCloud to Present at the Healthcare IT Conference Presented by Maxim Group LLC on Tuesday, July 12 at 11:00 a.m. EDT

SOMERSET, N.J., July 11, 2022 (GLOBE NEWSWIRE) — CareCloud, Inc. (the “Company”) (Nasdaq: MTBC, MTBCO, MTBCP), a leader in healthcare technology solutions for medical practices and health systems nationwide, announced today that CFO, Bill Korn, will be participating in a virtual panel, “Software for Doctors and Dentists,” at the Healthcare IT Virtual Conference, presented by Maxim Group LLC and hosted by M-Vest, on Tuesday, July 12, 2022, at 11:00 a.m. EDT. CareCloud’s software and services are used by 40,000 healthcare providers in all 50 states. This conference will be hosted live on M-Vest. To attend, please visit’s CareCloud’s investor relations site, ir.carecloud.com/events, and click on the Maxim Healthcare IT Conference. About CareCloud CareCloud (Nasdaq: MTBC, MTBCO, MTBCP) brings disciplined innovation to the business...

Continue reading

Society Pass (SoPa) Marks First Foray Into Thailand by Acquiring Bangkok-Headquartered Thoughtful Media Group, Southeast Asia’s Leading Digital Video Multi-Platform Network and Social Commerce Platform

SoPa acquires first company in Thailand and continues network expansion of its digital ecosystem throughout Southeast Asia (“SEA”) Thoughtful Media’s social commerce-focused Multi-Platform Network (“MPN”) in Thailand, Vietnam, Philippines and the US amplifies SoPa’s loyalty offering Thoughtful Media recorded revenues of US$5.8 million in 2021, forecasts significant revenue growth in 2022 and beyond Thoughtful Media’s data-rich MPN has uploaded over 675,000 videos with over 80 billion video views since 2010, and the current network of 263 YouTube Channels has onboarded over 85 million subscribers SoPa sees significant cross-marketing and revenue generation synergies between Thoughtful Media and rest of SoPa ecosystemSINGAPORE, July 11, 2022 (GLOBE NEWSWIRE) — via NewMediaWire – Society Pass Incorporated (“SoPa” or “Society...

Continue reading

Kala Pharmaceuticals Completes Sale of EYSUVIS® and INVELTYS® to Alcon Inc

ARLINGTON, Mass, July 11, 2022 (GLOBE NEWSWIRE) — Kala Pharmaceuticals, Inc. (NASDAQ:KALA), a clinical-stage biopharmaceutical company dedicated to the research, development and commercialization of innovative therapies for rare diseases of the eye, announced today that it has completed the sale of its commercial portfolio and related intellectual property assets to Alcon Inc., a transaction that was announced on May 23, 2022. The sale included EYSUVIS, the first and only U.S. Food and Drug Administration approved medicine for the short-term (up to two weeks) treatment of the signs and symptoms of dry eye disease, and INVELTYS, a twice-a-day corticosteroid for the treatment of post-operative inflammation and pain following ocular surgery. Under the terms of the transaction, Kala received an upfront payment of $60 million in cash...

Continue reading

Research 2022, Fitness Tracker Market Size Is Projected to Reach USD 114.36 Billion in 2028 while exhibiting a CAGR of 15.4%

According to Fortune Business Insights, The global Fitness Tracker Market is expected to reach USD 91.98 billion by 2027, exhibiting a CAGR of 15.2% during the forecast period. High Proclivity towards Fitness to Boost Demand for Fitness Trackers Pune, India, July 11, 2022 (GLOBE NEWSWIRE) — The global ”Fitness Tracker Market” is expected to reach USD 91.98 billion by 2027, exhibiting a CAGR of 15.2% during the forecast period. The rising adoption of wearable devices among the young population will significantly bolster healthy growth of the market, states Fortune Business Insights, in a report, titled “Fitness Tracker Market Size, Share &COVID-19 Impact Analysis, By Device Type (Smart Watches, Fitness Bands, Smart Glasses, Smart Clothing, and Others), By Application (Heart Rate Tracking, Sleep Measurement, Glucose Measurement,...

Continue reading

Watsco’s Earnings Call to Discuss Second Quarter Results Scheduled on July 26, 2022

MIAMI, July 11, 2022 (GLOBE NEWSWIRE) — Watsco, Inc. (NYSE: WSO) announced today that it will host a conference call to discuss its 2022 second quarter financial results on Tuesday, July 26, 2022 at 10:00 a.m. (EDT). Prepared remarks regarding the results will be followed by a question-and-answer session with the senior management team. The conference call will be web-cast by CCBN’s StreetEvents and can be found under the link highlighted on our website at www.watsco.com. The earnings results will be released before the market opens on July 26, 2022. A replay of the conference call will be available on our website. Investors and analysts are encouraged to pre-register for the conference call by using the link below. Participants who pre-register will be given a unique PIN to gain immediate access to the call. Pre-registration...

Continue reading

Wah Fu Education Group Ltd. Announces Cooperation with Sichuan International Studies University and Dotease Information for Online Education Platform Development

BEIJING, China, July 11, 2022 (GLOBE NEWSWIRE) — Wah Fu Education Group Limited (“Wah Fu” or the “Company”) (NASDAQ:WAFU), a provider of online education and exam preparation services, as well as related training materials and technology solutions for both institutions and individuals, today announced that it’s wholly-owned subsidiary, Beijing Huaxia Dadi Distance Learning Services Co., Ltd., entered into a cooperation agreement with Sichuan International Studies University (“SISU”) for the development of Online and Continuing Education College’s Online Course Platform. Additionally, the Company’s majority-owned subsidiary, Huafu Wanrun (Guangzhou) Education Technology Co., Ltd, also entered into a cooperation agreement with Dotease Information Technology Co., Ltd. (“Dotease Information”) for the development of the Vocational...

Continue reading

Hillman Sets Second Quarter 2022 Earnings Release and Results Presentation Date

CINCINNATI, July 11, 2022 (GLOBE NEWSWIRE) — Hillman Solutions Corp. (Nasdaq: HLMN) (the “Company” or “Hillman”), a leading provider of hardware products and merchandising solutions, plans to host a conference call to discuss its results for the thirteen and twenty-six weeks ended June 25, 2022 on Wednesday, August 3, 2022 at 8:30 a.m. Eastern Time. Hillman will issue its earnings release on the same day prior to the results presentation. Chairman, President, and Chief Executive Officer Doug Cahill and Chief Financial Officer Rocky Kraft will host the results presentation.Results Presentation Details:  Date: August 3, 2022  Time: 8:30 am Eastern Time  Audio-Only Webcast: https://edge.media-server.com/mmc/p/3awwmvtvResearch analysts wishing to participate in the call’s live question and answer session must register...

Continue reading

EyePoint Pharmaceuticals to Host Investor Day on July 18, 2022

– Guest speakers Carl Regillo, M.D., FACS, Professor of Ophthalmology, Thomas Jefferson University and Charles C. Wykoff, M.D., Ph.D., Director of Research, Retina Consultants of Texas – WATERTOWN, Mass., July 11, 2022 (GLOBE NEWSWIRE) — EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a pharmaceutical company committed to developing and commercializing therapeutics to improve the lives of patients with serious eye disorders, today announced it will host an Investor Day that will be held on Monday, July 18, 2022 from 8:00 a.m. to 11:00 a.m. ET. The Investor Day will feature commentary from EyePoint’s management team as well as key opinion leader guest speakers Carl D. Regillo, M.D., FACS, Professor of Ophthalmology, Thomas Jefferson University and Charles C. Wykoff, M.D., Ph.D., Director of Research, Retina Consultants...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.